191 related articles for article (PubMed ID: 36543894)
1. Mesenchymal stem cells ameliorate cisplatin-induced acute kidney injury via let-7b-5p.
Wang SY; Xu Y; Hong Q; Chen XM; Cai GY
Cell Tissue Res; 2023 May; 392(2):517-533. PubMed ID: 36543894
[TBL] [Abstract][Full Text] [Related]
2. Exosomal miR-125b-5p deriving from mesenchymal stem cells promotes tubular repair by suppression of p53 in ischemic acute kidney injury.
Cao JY; Wang B; Tang TT; Wen Y; Li ZL; Feng ST; Wu M; Liu D; Yin D; Ma KL; Tang RN; Wu QL; Lan HY; Lv LL; Liu BC
Theranostics; 2021; 11(11):5248-5266. PubMed ID: 33859745
[TBL] [Abstract][Full Text] [Related]
3. Three-dimensional culture of MSCs produces exosomes with improved yield and enhanced therapeutic efficacy for cisplatin-induced acute kidney injury.
Cao J; Wang B; Tang T; Lv L; Ding Z; Li Z; Hu R; Wei Q; Shen A; Fu Y; Liu B
Stem Cell Res Ther; 2020 May; 11(1):206. PubMed ID: 32460853
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow-derived mesenchymal stem cells protect against cisplatin-induced acute kidney injury in rats by inhibiting cell apoptosis.
Qi S; Wu D
Int J Mol Med; 2013 Dec; 32(6):1262-72. PubMed ID: 24126885
[TBL] [Abstract][Full Text] [Related]
5. Exosomal‑miR‑1184 derived from mesenchymal stem cells alleviates cisplatin‑associated acute kidney injury.
Zhang J; He W; Zheng D; He Q; Tan M; Jin J
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34515319
[TBL] [Abstract][Full Text] [Related]
6. microRNA-486-5p is implicated in the cisplatin-induced apoptosis and acute inflammation response of renal tubular epithelial cells by targeting HAT1.
Lin FY; Han ST; Yu WM; Rao T; Ruan Y; Yuan R; Li HY; Ning JZ; Xia YQ; Xie JN; Qi YC; Zhou XJ; Cheng F
J Biochem Mol Toxicol; 2022 Jun; 36(6):e23039. PubMed ID: 35279909
[TBL] [Abstract][Full Text] [Related]
7. Bone Marrow Mesenchymal Stem Cells Ameliorate Cisplatin-Induced Renal Fibrosis
Wu L; Rong C; Zhou Q; Zhao X; Zhuansun XM; Wan S; Sun MM; Wang SL
Front Immunol; 2020; 11():623693. PubMed ID: 33664736
[TBL] [Abstract][Full Text] [Related]
8. Human umbilical cord-derived mesenchymal stem cell therapy ameliorates lupus through increasing CD4+ T cell senescence via MiR-199a-5p/Sirt1/p53 axis.
Cheng T; Ding S; Liu S; Li Y; Sun L
Theranostics; 2021; 11(2):893-905. PubMed ID: 33391511
[No Abstract] [Full Text] [Related]
9. miR-644-5p carried by bone mesenchymal stem cell-derived exosomes targets regulation of p53 to inhibit ovarian granulosa cell apoptosis.
Sun B; Ma Y; Wang F; Hu L; Sun Y
Stem Cell Res Ther; 2019 Nov; 10(1):360. PubMed ID: 31783913
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-146b, a Sensitive Indicator of Mesenchymal Stem Cell Repair of Acute Renal Injury.
Zhu Y; Yu J; Yin L; Zhou Y; Sun Z; Jia H; Tao Y; Liu W; Zhang B; Zhang J; Wang M; Zhang X; Yan Y; Xue J; Gu H; Mao F; Xu W; Qian H
Stem Cells Transl Med; 2016 Oct; 5(10):1406-1415. PubMed ID: 27400799
[TBL] [Abstract][Full Text] [Related]
11. Clinical-grade human skin-derived ABCB5+ mesenchymal stromal cells exert anti-apoptotic and anti-inflammatory effects
Rendra E; Crigna AT; Daniele C; Sticht C; Cueppers M; Kluth MA; Ganss C; Frank MH; Gretz N; Bieback K
Front Immunol; 2023; 14():1228928. PubMed ID: 38274791
[TBL] [Abstract][Full Text] [Related]
12. Macrophage-derived exosomal miR-195a-5p impairs tubular epithelial cells mitochondria in acute kidney injury mice.
Yuan L; Yang J; Liu F; Li L; Liu J; Chen Y; Cheng J; Lu Y; Yuan Y
FASEB J; 2023 Jan; 37(1):e22691. PubMed ID: 36515680
[TBL] [Abstract][Full Text] [Related]
13. p53 inhibition attenuates cisplatin-induced acute kidney injury through microRNA-142-5p regulating SIRT7/NF-κB.
Chen G; Xue H; Zhang X; Ding D; Zhang S
Ren Fail; 2022 Dec; 44(1):368-380. PubMed ID: 35220863
[TBL] [Abstract][Full Text] [Related]
14. miR-100-5p-abundant exosomes derived from infrapatellar fat pad MSCs protect articular cartilage and ameliorate gait abnormalities via inhibition of mTOR in osteoarthritis.
Wu J; Kuang L; Chen C; Yang J; Zeng WN; Li T; Chen H; Huang S; Fu Z; Li J; Liu R; Ni Z; Chen L; Yang L
Biomaterials; 2019 Jun; 206():87-100. PubMed ID: 30927715
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal Stem Cells: a Promising Therapeutic Tool for Acute Kidney Injury.
Selim RE; Ahmed HH; Abd-Allah SH; Sabry GM; Hassan RE; Khalil WKB; Abouhashem NS
Appl Biochem Biotechnol; 2019 Sep; 189(1):284-304. PubMed ID: 30976980
[TBL] [Abstract][Full Text] [Related]
16. Exosomes derived from mesenchymal stem cells attenuate diabetic kidney disease by inhibiting cell apoptosis and epithelial-to-mesenchymal transition via miR-424-5p.
Cui C; Zang N; Song J; Guo X; He Q; Hu H; Yang M; Wang Y; Yang J; Zou Y; Gao J; Wang L; Wang C; Liu F; He F; Hou X; Chen L
FASEB J; 2022 Oct; 36(10):e22517. PubMed ID: 36036527
[TBL] [Abstract][Full Text] [Related]
17. MBD2 upregulates miR-301a-5p to induce kidney cell apoptosis during vancomycin-induced AKI.
Wang J; Li H; Qiu S; Dong Z; Xiang X; Zhang D
Cell Death Dis; 2017 Oct; 8(10):e3120. PubMed ID: 29022913
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal Stem Cells Attenuate Renal Fibrosis via Exosomes-Mediated Delivery of microRNA Let-7i-5p Antagomir.
Jin J; Qian F; Zheng D; He W; Gong J; He Q
Int J Nanomedicine; 2021; 16():3565-3578. PubMed ID: 34079249
[TBL] [Abstract][Full Text] [Related]
19. Exosomes derived from M1 macrophages inhibit the proliferation of the A549 and H1299 lung cancer cell lines via the miRNA-let-7b-5p-GNG5 axis.
Peng J; Li S; Li B; Hu W; Ding C
PeerJ; 2023; 11():e14608. PubMed ID: 36643646
[TBL] [Abstract][Full Text] [Related]
20. p53 induces miR-199a-3p to suppress mechanistic target of rapamycin activation in cisplatin-induced acute kidney injury.
Yang A; Liu F; Guan B; Luo Z; Lin J; Fang W; Liu L; Zuo W
J Cell Biochem; 2019 Oct; 120(10):17625-17634. PubMed ID: 31148231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
